AHRP InfoMail Return to Home Page Return to InfoMail Media Coverage List MediaCoverage News Stories on Human ResearchProtection andCommentary by Vera Hassner Sharav April 12, 2002 If Placebo Works Without Risk,Side-Effects or Cost — Why Prescribe Anti-Depressant Drugs? FYI As we reported in yesterday’s Infomail, a major governmentfunded study found…
AHRP InfoMail Return to Home Page Return to InfoMail Media Coverage List MediaCoverage News Stories on Human ResearchProtection andCommentary by Vera Hassner Sharav April 10, 2002 For Relief of ModeratelySevere Depression, Study Shows No Significance Difference Among Placebo, Zoloftand St. Johns Wort — JAMA FYI The findings of a major…
Coroner calls for withdrawal of Seroxat (PAXIL) March 13, 2002 Following the death of a 56 year old retired headmaster within two weeks of taking the antidepressant, Seroxat (PAXIL), a British coroner told a court “”I have grave concerns that this is a dangerous drug that should be withdrawn until…
AHRP InfoMail Return to Home Page Return to InfoMail Media Coverage List MediaCoverage News Stories on Human ResearchProtection andCommentary by Vera Hassner Sharav March 5, 2002 Placebo Trials and Tribulations FYI An interesting article by Dr. Charles Weijer addresses thedebate about the ethics of conducting placebo controlled clinical trials inpatients,…
2000 Study by Merck Showed Vioxx Risk: Results Not Given to FDA – Star Ledger Sun, 3 Jul 2005 News reports reveal that Merck failed to disclose Vioxx lethal effects to the FDA. Sheldon Krimsky, a science policy expert at Tufts University states: “if there was evidence the drug was…
July 14, 2000. New FDA Warning about fatal risk linked to Melaril after 40 years! FYI For 40 years schizophrenia patients have been prescribed Mellaril, a drug that the FDA finally acknowledges causes sudden death due to cardiac arrest! Why did it take the FDA 40 years before it sent…
